“Formulation and Evaluation of Titanium Dioxide Nanoparticles encapsulating Enzalutamide for Sustained drug delivery” (2025) Journal of Carcinogenesis, 24(8s), pp. 458–467. doi:10.64149/J.Carcinog.24.8s.458-467.